title: Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
abstract: We assessed the prevalence of post-kala-azar dermal leishmaniasis (PKDL), a late cutaneous manifestation of visceral leishmaniasis (VL), in 16 VL-endemic communities in Bihar, India. The prevalence of confirmed PKDL cases was 4.4 per 10 000 individuals and 7.8 if probable cases were also considered. The clinical history and treatment of the post-kala-azar dermal leishmaniasis cases are discussed.
authors.affiliation: Banaras Hindu University, Varanasi, India  Institute of Tropical Medicine, Antwerp, Belgium  Barcelona Centre for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain  Geneva University Hospitals, Geneva, Switzerland.
authors.forename: Rudra Pratap
authors.initials: RP
authors.lastname: Singh
authors.forename: Albert
authors.initials: A
authors.lastname: Picado
authors.forename: Shahnawaz
authors.initials: S
authors.lastname: Alam
authors.forename: Epco
authors.initials: E
authors.lastname: Hasker
authors.forename: Shri Prakash
authors.initials: SP
authors.lastname: Singh
authors.forename: Bart
authors.initials: B
authors.lastname: Ostyn
authors.forename: François
authors.initials: F
authors.lastname: Chappuis
authors.forename: Shyam
authors.initials: S
authors.lastname: Sundar
authors.forename: Marleen
authors.initials: M
authors.lastname: Boelaert
mesh_terms: D000293:Adolescent; D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002648:Child; D019353:Endemic Diseases; D005260:Female; D006801:Humans; D007194:India / Q000453:epidemiology; D007893:Leishmania donovani / Q000302:isolation & purification*; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy / Q000453:epidemiology*; D007898:Leishmaniasis, Visceral / Q000188:drug therapy / Q000453:epidemiology*; D008297:Male; D015995:Prevalence; D012720:Severity of Illness Index
chemical_list: D000981:Antiprotozoal Agents